Myriad Genetics, Inc. (MYGN) Financials
MYGN Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-12-31 | 1.1 billion | 363.3 million |
| 2023-09-30 | 1.1 billion | 465.7 million |
| 2023-06-30 | 1.2 billion | 452.0 million |
| 2023-03-31 | 1.2 billion | 334.1 million |
MYGN Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-12-31 | -68.2 million | 10.4 million |
| 2023-09-30 | -39.6 million | 11.6 million |
| 2023-06-30 | -19.7 million | 11.2 million |
| 2023-03-31 | -56.7 million | 7.5 million |
MYGN Net Income
Graph available only for supporters. Become a supporter to see it.
| Date | Net Income |
|---|---|
| 2023-12-31 | -31.2 million |
| 2023-09-30 | -61.3 million |
| 2023-06-30 | -116.1 million |
| 2023-03-31 | -54.7 million |
MYGN Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-12-31 | - | - | 113.6 million |
| 2023-09-30 | 86.3 million | - | 162.9 million |
| 2023-06-30 | 121.6 million | - | 165.4 million |
| 2023-03-31 | 78.7 million | - | 161.6 million |
MYGN Shares Outstanding
MYGN Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-12-31 | 13.5 million | 21.0 million | 32.6 million | - |
| 2023-09-30 | 17.5 million | 24.0 million | 170.4 million | - |
| 2023-06-30 | 18.8 million | 21.2 million | 218.2 million | - |
| 2023-03-31 | 23.5 million | 22.5 million | 151.7 million | - |
MYGN Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-12-31 | 196.6 million | 61.6 million |
| 2023-09-30 | 191.9 million | 57.6 million |
| 2023-06-30 | 183.5 million | 57.8 million |
| 2023-03-31 | 181.2 million | 59.2 million |
MYGN
Price: $25.29
52 week price:
Earnings Per Share: -3.18 USD
P/E Ratio: -6.54
Exchange: NMS
Sector: Healthcare
Industry: Diagnostics & Research
Volume: 315100
Ebitda: 17.5 millionMarket Capitalization: 2.3 billion